FDA Product Code KRA: Catheter, Continuous Flush
FDA product code KRA covers continuous flush catheters used for hemodynamic pressure monitoring.
These catheters incorporate a slow continuous infusion mechanism that maintains line patency and prevents thrombus formation in arterial pressure monitoring lines and pulmonary artery catheters. They deliver a controlled flush rate of 3 mL/hour without requiring manual flushing.
KRA devices are Class II medical devices, regulated under 21 CFR 870.1210 and reviewed by the FDA Cardiovascular panel.
Leading manufacturers include Micro Therapeutics, Inc., Cordis Neurovascular, Inc. and Cook, Inc..
FDA 510(k) Cleared Catheter, Continuous Flush Devices (Product Code KRA)
About Product Code KRA - Regulatory Context
510(k) Submission Activity
177 total 510(k) submissions under product code KRA since 1977, with 177 receiving FDA clearance (average review time: 123 days).
Submission volume has remained relatively stable over the observed period, with 6 submissions in the last 24 months.
FDA 510(k) Review Time - KRA Product Code
Recent submissions under KRA have taken an average of 217 days to reach a decision - up from 120 days historically. Manufacturers should account for longer review timelines in current project planning.
KRA devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →